Guy Barry, Paul Baldock
2020
Private company
Altered intercellular communication, Cell Loss
small molecule drugs
We at oncoLife Therapeutics foresee a future where optimising stem cell activity will hold the secrets to achieving healthy ageing and eliminating cancer.
At oncoLife, we are striving to identify the underlying molecular mechanisms driving age-related degenerative change in order to intervene when stem cell activity becomes excessive in the case of cancer (onco) or insufficient in the case of ageing (Life), and ultimately increase both lifespan and healthspan.